News | RIVM

From 1 October 2023, heel prick test also screens for metabolic disorder ALD

From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.

Number of tuberculosis patients in the Netherlands decreased slightly in 2022 compared to 2021

The number of people with tuberculosis (TB) in the Netherlands decreased slightly in 2022. In 2022, there were 635 TB patients in the Netherlands. This is six per cent fewer than in 2021, when there were 673 patients.

NIPT available as standard option for all pregnant women from 1 April

From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.

COVID-19 vaccine uptake related to neighbourhood demographics

COVID-19 vaccine uptake was lower in neighbourhoods that had proportionately higher percentages of residents from a non-Western migration background and residents who were more likely to vote for right-wing Christian and right-wing conservative political parties.

iStock

Vaccination coverage for autumn round: Downward trend in Health & Welfare sector continues – 69% of nationwide medical high-risk groups were vaccinated

At the start of the autumn round, from mid-September 2022, the first group to be offered a repeat vaccination against COVID-19 was people with an elevated risk of a severe course of illness and care workers who have contact with patients and/or clients

Zorgmedewerker ontvangt de booster vaccinatie (Covid-19)

Annual report ‘Tuberculosis in the Netherlands’ for 2021: slight increase in number of TB patients

In 2021, the number of tuberculosis (TB) patients in the Netherlands rose slightly compared to the preceding year: up to 680 TB patients from 622 in 2020. However, the 2021 number was lower than the number for 2019 (754 patients).

COVID-19 vaccination estimated to have prevented about 88 thousand hospital admissions in just over one year

The COVID-19 vaccinations prevented many hospital admissions in the Netherlands.

Cancer screening programmes now more accessible to transgender and intersex persons

Since October 2022, is it has become easier for transgender and intersex persons to take part in cervical cancer screening and breast cancer screening. Transgender and intersex persons with a uterus and/or breast tissue can register with Bevolkingsonderzoek Nederland.

First vaccination figures for autumn round of COVID-19 repeat vaccination

From this week on, RIVM will start posting updates on vaccination figures for the autumn round of the repeat vaccination against COVID-19. The autumn round started last week, on 19 September 2022.

Repeat vaccination against COVID-19: risk groups first, then everyone 12 and up

The first invitations for a repeat vaccination against COVID-19 will be received by people in the Netherlands on 13 September 2022. RIVM will invite the oldest people first, and will then send an invitation to everyone aged 60 years and older.